ALNY To Face FDA In Feb., PODD Ups Outlook Again, Catalysts Galore For XLRN

Today's Daily Dose brings you news about Cardiovascular Systems's acquisition; upcoming catalysts of Revance Therapeutics and Acceleron Pharma; Insulet's stellar revenue outlook; and Axonics's Q2 financial results, to name a few.

from RTT - Biotech https://ift.tt/2YLigj4
via IFTTT